The Role of Dermocosmetics in the Management of Cancer-Related Skin Toxicities: International Expert Consensus

November 2023 in “ Supportive Care in Cancer ”

Brigitte Dréno, Kiarash Khosrotehrani, Giselle de Barros Silva, Julie Ryan Wolf, Delphine Kérob, Mark Trombetta, Etienne Atenguena, Pascale Dielenseger, Meng Pan, Florian Scotté, I. Krakowski, Mario E. Lacouture

Studysummary In this publication, a collaborative group reviewed the role of dermocosmetics in cancer care and formulated recommendations for using these products to manage skin toxicities and minimize treatment interruptions associated with cancer therapies. Our plain-language summary of this paper — not a Tressless recommendation.

Dermocosmetics, which are skincare solutions with dermatologically active ingredients, are increasingly used to manage skin toxicities in cancer patients undergoing various treatments. These skin toxicities can lead to interruptions or discontinuation of cancer therapies, resulting in suboptimal outcomes. The Association Francophone des Soins Oncologiques de Support (AFSOS) and the Multinational Association of Supportive Care in Cancer (MASCC) collaborated with a multidisciplinary group of healthcare professionals to review literature and develop recommendations for using dermocosmetics to prevent and manage these toxicities. The group highlights the importance of dermocosmetics in maintaining skin integrity and relieving symptoms, thereby improving patient outcomes and minimizing treatment interruptions. They provide general guidelines for the use of skincare in oncology patients and specific recommendations for different types of skin toxicities.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Oral Minoxidil for Late Alopecia in Cancer Survivors

14 citations , August 2024 in “Breast Cancer Research and Treatment”

This study found that oral minoxidil improved hair density in women experiencing late alopecia due to chemotherapy and/or endocrine therapy, with 74% showing clinical improvement and statistically significant increases in hair shaft density reported in those assessed with trichoscopy.

research Platelet-Rich Plasma in the Treatment of Alopecia Areata After COVID-19 Vaccination

2 citations , May 2023 in “Clinical case reports”

In this case report, a 34-year-old woman developed severe alopecia areata after her second COVID-19 vaccination, but her hair fully recovered following six platelet-rich plasma treatments, highlighting PRP as a potential alternative for patients who cannot tolerate or do not respond to corticosteroids.

research Oral Minoxidil for the Treatment of Late Alopecia in Cancer Survivors

1 citations , June 2022 in “Journal of Clinical Oncology”

This study found that oral minoxidil may improve hair density in cancer survivors experiencing late alopecia due to chemotherapy and/or endocrine therapy, with patients tolerating the treatment well.

An Emollient Plus Balm Is Useful for the Management of Xerosis in Cancer Patients: A Real-World, Prospective, Observational, Multicenter Study

research An Emollient Plus Balm Is Useful for the Management of Xerosis in Cancer Patients: A Real-World, Prospective, Observational, Multicenter Study

9 citations , February 2022 in “Dermatology and therapy”

This study found that daily use of an emollient PLUS containing ADE-G1 significantly reduced xerosis severity and improved quality of life in cancer patients, regardless of their initial xerosis severity or cancer treatment.

research Cutaneous Adverse Events to Systemic Antineoplastic Therapies: A Retrospective Study in a Public Oncologic Hospital

7 citations , November 2021 in “Anais Brasileiros de Dermatologia”

This retrospective study found a variety of dermatological adverse events associated with antineoplastic treatments, often leading to changes or suspension of cancer therapies in affected patients.

research Prevention And Management Of Dermatological Toxicities Related To Anticancer Agents: ESMO Clinical Practice Guidelines

86 citations , November 2020 in “Annals of Oncology”

These guidelines discuss prevention and management strategies for dermatological toxicities but report no new clinical results; they include expert recommendations for conditions like acneiform rash and hand-foot syndrome.

research Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date

32 citations , March 2020 in “Drug Design Development and Therapy”

This review examines the pharmacology, clinical efficacy, and adverse effects of oral finasteride for female pattern hair loss, and discusses potential new treatments like topical finasteride and dutasteride, but reports no new clinical results.

research Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails

179 citations , October 2018 in “American Journal of Clinical Dermatology”

This review outlines various dermatologic adverse events associated with targeted therapies and immunotherapies, emphasizing the need for collaboration between dermatologists and oncologists to manage these effects effectively; it reports no new clinical findings.

research Classification and Management of Skin, Hair, Nail, and Mucosal Side Effects of Epidermal Growth Factor Receptor Inhibitors

138 citations , February 2007 in “European journal of cancer”

This review discusses the classification, pathogenesis, and management of skin, hair, nail, and mucosal changes due to EGFR inhibitors, emphasizing the importance of informing patients to improve therapy compliance.